Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

FDA approves Photofrin PDT for high-grade dysplasia in Barrett's esophagus

Aug. 6, 2003

ARS scientists design GILZ-based peptides for use in cancer, inflammation, etc.

Aug. 6, 2003

New antitumor agents in Kyowa Hakko development pipeline

Aug. 6, 2003

Fulvestrant at least as effective as anastrozole in advanced breast cancer

Aug. 6, 2003

MorphoSys and Schering AG collaboration yields positive animal data

Aug. 6, 2003

Maxim discusses discovery and development of apoptosis inducers at cancer meeting

Aug. 5, 2003

Small-molecule Bcl-2 inhibitor with apoptosis-inducing effects in cancer cells

Aug. 5, 2003

Bexxar launched in U.S.

Aug. 5, 2003

Additional mechanism of action for IGN-311: inhibition of growth factor signaling

Aug. 4, 2003

AVE-8062A: a tumor vasculature targeting agent with promising antitumor activity

Aug. 4, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.